Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Larotrectinib Sulfate Capsules

Approval Number

国药准字HJ20220033

CompanyBAYER AG

Registration Date

April 8, 2022

Drug Information

Generic Name

硫酸拉罗替尼胶囊

Trade Name

维泰凯

Dosage Form

胶囊剂

Strength

100mg（按C21H22F2N6O2计）

Drug Type

化学药品

Registration Date

April 8, 2022

Expiry Date

April 7, 2027

Company Information

Applicant Company

Company NameBAYER AG

Company Address

51368 Leverkusen, Germany

Manufacturing Company

Company NamePENN PHARMACEUTICAL SERVICES LIMITED

Company Address

Units 23-24, Tafarnaubach Industrial Estate, Gwent,Tredegar, NP22 3AA, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy